| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 285 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1061 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1301 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1355 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 1726 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 2244 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 2616 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 2963 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 3463 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 3671 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 4153 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 5239 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 5561 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 6332 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 6512 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 7277 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 7539 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 11175 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 11641 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 12571 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 12659 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 12840 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 12991 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 13339 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 13355 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 13587 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 13765 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 13833 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 14574 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 14587 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 14652 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 15156 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 15351 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 16494 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 16916 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 17764 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 18226 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 18425 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 18644 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 19382 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 19980 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 20120 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 22315 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 23633 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 24039 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 24965 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 25400 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 25981 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 32316 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 36244 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 37384 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 41178 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 44331 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | 4-hydroxybenzoate | 46996 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|